SEC Form 4 · accession 0001493152-26-040274
Neuraxis, INC · NRXS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Allen Carrico
Officer — Chief Executive Officer · Director
Period of report
Aug 24, 2026
Accepted (ET)
Aug 26, 2026 · 5:29 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001933567
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 24, 2026 | A | 199,188 | — | A | 227,336 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2 | — | Aug 24, 2026 | C | 320,000 | D | — | — | Common Stock | 320,000 | 0 | D |
| RSUF2 | — | Aug 24, 2026 | A | 320,000 | A | — | — | Common Stock | — | 320,000 | D |
| RSUF2 | — | Aug 24, 2026 | C | 320,000 | D | — | — | Common Stock | — | 0 | D |
Explanation of responses
- F1Reference is made to the 320,000 restricted stock units ("RSUs") granted and vested to the Reporting Person under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan as discussed below, of which 120,812 shares were withheld by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting of RSUs.
- F2Following approval by the Company's Board of Directors and stockholders of the cancellation of stock options issued under the 2017 Innovative Health Solutions, Inc. Stock Compensation Plan and the grant of an equivalent number of RSUs under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan, the reporting person's stock options were canceled in exchange for an equivalent number of RSUs, which vested immediately upon grant.